pharma news today obesity drugs glp-1 A $60 billion industry just found its next growth lever. π With the expiry of a key patent on March 20, 2026, Indian majors are launching generic weight-loss and diabetes GLP-1 Pill Helped People With
Description
doi: 10.3390/cells13010065
Their formulations are rooted in cutting-edge microbiome science and designed to support metabolism, gut barrier health, and even cravings while helping to maintain healthy blood sugar* by delivering next-generation, live probiotic strains to the gut
3.Zepbound
Herbert A, Wijlaars L, Zylbersztejn A, Cromwell D, Hardelid P
The third wave, which is perhaps more of an open question than the first two, is whether hepatic safety can be reliably designed out
In obese mice, VK2735 shows effects comparable to semaglutide, reducing body weight by up to 26.67% in 20 days
